IbrahimN.K., HortobagyiG.N., EwerM.: Doxorubicin-in-duced congestive heart failure in elderly patients with metastatic breast cancer, with long-term follow-up: the MD Anderson experience. Cancer Chemother Pharmacol, 43: 471–478, 1999.
CasazzaA., BarbieriB., FumagalliA.: Biologic activity of 4-demethoxy-13- dihydrodaunorubicin (4-dm-13-OH-DNR). Proc Am Ass Cancer Res, 24: 251, 1983.
4.
ToffoliG., SorioR., AitaP., CrivellariD.: Dose-finding and pharmacologic study of chronic oral idarubicin therapy in metastatic breast cancer patients. Clinical Cancer Res, 6: 2279–2287, 2000.
5.
ToffoliG., CrivellariD., MagriM.D.: Innovative schedule of oral idarubicin (IDA) in elderly patients with metastatic breast cancer: a phase II study. Proc 25th ESMO Congress, 37(abstr 156), Hamburg, 2000.
